ErbB4

ErbB4 분자 정보

영어 이름Receptor protein-tyrosine kinase erbB-4시판 약물 수5
임상 약물 수12표적 별명EC 2.7.10,EC:2.7.10.1,ERBB4,Tyrosine kinase-type cell surface receptor HER4,s80HER4,p180erbB4,Receptor tyrosine-protein kinase erbB-4,4ICD,E4ICD,HER4,Erb-B2 Receptor Tyrosine Kinase 4,V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4,Human Epidermal Growth Factor Receptor 4,Proto-Oncogene-Like Protein C-ErbB-4,V-Erb-A Avian Erythroblastic Leukemia Viral Oncogene Homolog-Like 4,Avian Erythroblastic Leukemia Viral (V-Erb-B2) Oncogene Homolog 4,V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 4,ERBB4 Transcript Variant I12DEL,ERBB4 Transcript Variant I20DEL,EC 2.7.10.1,ALS19,Receptor, ErbB-4
최고 연구 개발 단계Approved
영어 이름Receptor protein-tyrosine kinase erbB-4
표적 별명EC 2.7.10,EC:2.7.10.1,ERBB4,Tyrosine kinase-type cell surface receptor HER4,s80HER4,p180erbB4,Receptor tyrosine-protein kinase erbB-4,4ICD,E4ICD,HER4,Erb-B2 Receptor Tyrosine Kinase 4,V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4,Human Epidermal Growth Factor Receptor 4,Proto-Oncogene-Like Protein C-ErbB-4,V-Erb-A Avian Erythroblastic Leukemia Viral Oncogene Homolog-Like 4,Avian Erythroblastic Leukemia Viral (V-Erb-B2) Oncogene Homolog 4,V-Erb-A Erythroblastic Leukemia Viral Oncogene Homolog 4,ERBB4 Transcript Variant I12DEL,ERBB4 Transcript Variant I20DEL,EC 2.7.10.1,ALS19,Receptor, ErbB-4
시판 약물 수5
임상 약물 수12
최고 연구 개발 단계Approved

ErbB4 제품 목록

  • 속성

    Protein (3)

  • 제품 라이브러리

    온라인 (3)

  • Human (3)

  • 태그

    His Tag (1)Fc Tag (1)His Tag & Avi Tag (1)

  • 마커

    Unconjugated (2)Biotin-labeled (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
Human
HEK293
Human ErbB4 / Her4 Protein, His Tag
Human
HEK293
Human ErbB4 / Her4 Protein, Fc Tag
Human
HEK293
Biotinylated Human ErbB4 / Her4 Protein, His,Avitag™ (MALS verified)
총 수량3
  • 1

ErbB4분자 배경

Receptor tyrosine-protein kinase erbB-4 (ErbB4), also known as Her4, is a single-pass type I transmembrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors. ErbB4 is expressed in normal skeletal muscle, heart, pituitary, brain and several breast carcinomas. ERBB4 contains multiple furin-like cysteine rich domains, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins-2 and -3, heparin-binding EGF-like growth factor and betacellulin. Ligand binding induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. ErbB4 appears to play important roles in neuronal development, development of the heart and cancer. ERBB4 has been shown to interact with: DLG4, NRG1, STAT5A, and YAP1. Mutations in this gene have been associated with cancer. Other single-nucleotide polymorphisms and a risk haplotype have been linked to schizophrenia.

ErbB4분자 별명

HER4,ErbB4,MGC138404,p180erbB4

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Recombinant human neuregulin-1rhNRG-1Phase 3 ClinicalZensun (Shanghai) Sci&Tech Co LtdHeart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Myocardial Infarction
상세
Larotinib MesylateZ-650Phase 3 ClinicalGuangdong Dongyangguang Pharmaceutical Co LtdEsophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Pancreatic Neoplasms; Solid tumours
상세
Allitinib TosylateAST-6; ALS-1306; AST-1306Phase 2 ClinicalShanghai Allist Pharmaceutical Technology Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung
상세
Varlitinib DitosylateSPS-4370; ASLAN-001; ARRY-334543; ARRY-543; QBT-01Phase 2 ClinicalArray BiopharmaBile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Metastatic breast cancer; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
상세
Neratinib (Fukang (Shanghai) Health Technology)CVL009; CVL-009Phase 2 ClinicalConvalife (Shanghai) Co LtdCarcinoma, Non-Small-Cell Lung; Solid tumours; Uterine Neoplasms
상세
EO-1001NT-113; APL-122Phase 2 ClinicalEdison Pharmaceuticals IncNeoplasms
상세
JRF-103JRF103; JRF-103Phase 2 ClinicalShenzhen Jinrui Foundation Biotechnology Co LtdSolid tumours
상세
Pirotinib HydrochlorideKBP-5209Phase 2 ClinicalShandong Xuanzhu Pharmaceutical Technology Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Solid tumours
상세
PB-357PB-357Phase 1 ClinicalPfizer IncNeoplasms
상세
Sirotinib MaleateXZP-5491Phase 1 ClinicalShandong Xuanzhu Pharmaceutical Technology Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Stomach Neoplasms
상세
XZP-5209XZP-5209Phase 1 ClinicalXuanzhu (Shijiazhuang) Biotechnology Co LtdCarcinoma, Non-Small-Cell Lung
상세
FCN-411FCN-411Phase 1 ClinicalCarcinoma, Non-Small-Cell Lung; Lung Neoplasms
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Osimertinib MesylateAZD-9291; RDL94R2A16; AZD-9291 Mesylate; AZD9291ApprovedAstrazeneca Plc泰瑞沙, TagrissoUnited StatesCarcinoma, Non-Small-Cell LungAstrazeneca Pharmaceutical Co Ltd2015-11-13Adenocarcinoma; Adenocarcinoma of Lung; Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Multiple Myeloma; Neoplasm, Residual; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms
상세
Afatinib DimaleateBIBW-2992-MA2; BIBW-2992ApprovedC.H. Boehringer Sohn Ag & Co. KgGilotrif, Giotrif, Tovok, 吉泰瑞, TomtovokUnited StatesCarcinoma, Non-Small-Cell LungC.H. Boehringer Sohn Ag & Co. Kg2013-07-12Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chordoma; Colorectal Neoplasms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gallbladder Neoplasms; Gastroesophageal Junction Neoplasms; Glioblastoma; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Liver Diseases; Lung Neoplasms; Lymphoma; Multiple Myeloma; Neoplasm Metastasis; Neoplasms; Neoplasms, Squamous Cell; Neuroectodermal Tumors; Penile Squamous Cell Carcinoma; Prostatic Neoplasms; Renal Insufficiency; Rhabdomyosarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Uterine Neoplasms
상세
Neratinib MaleateHKI-272; PF-0528767; WAY-179272; CAN-030; PB-272ApprovedPfizer IncNerlynx, 贺俪安, 汉奈佳, 赫赛佳, HerneraUnited StatesBreast NeoplasmsPuma Biotechnology Inc2017-07-17Brain metastases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Glioblastoma; Hepatic Insufficiency; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
Pyrotinib MaleateBLTN; HTI-1001; SHR-1258ApprovedJiangsu Hengrui Medicine Co Ltd艾瑞妮Mainland ChinaBreast NeoplasmsJiangsu Hengrui Medicine Co Ltd2018-08-12Adenocarcinoma of Lung; Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Solid tumours; Stomach Neoplasms
상세
DacomitinibPF-00299804-03; PF-00299804-3; PF-00299804; PF-299804; PF-299; PF-804ApprovedPfizer IncVizimproUnited StatesCarcinoma, Non-Small-Cell LungPfizer Inc2018-09-27Adenocarcinoma; Brain Neoplasms; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Glioblastoma; Head and Neck Neoplasms; Liver Diseases; Lung Neoplasms; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms; Penile Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호